CycloGen AI was founded by Linu Lawrence, an HPC architect and biomedical computing specialist with over a decade of experience building GPU-accelerated infrastructure, AI pipelines, and computational platforms for biomedical research.
During his work supporting biomedical labs, Linu noticed a recurring challenge:
"Drug discovery tools were fragmented, slow, and required expert knowledge to operate. AI tools existed — but none were unified into a single intelligent platform."
Motivated to solve this, he began designing a new kind of molecular engineering engine — one capable of turning raw biological sequences into drug-ready molecules within minutes.
That vision became CycloGen AI.
Today, CycloGen AI is a no-code intelligent platform that integrates protein structure prediction, pocket detection, binder engineering, ligand generation and ranking, immuno-design, antiviral inhibitor discovery, mutation impact analysis, and AI reasoning models — all within a unified platform.
CycloGen AI empowers scientists, biotech startups, academic labs, and pharmaceutical teams to accelerate discovery, reduce costs, and design breakthrough therapeutics in silico.
To accelerate molecular discovery by building the fastest and most intelligent no-code AI platform for drug discovery and protein engineering.
A future where designing therapeutic molecules is faster, more intelligent, and accessible through integrated AI-driven molecular engineering platforms.
Linu Lawrence
HPC Architect • Biomedical Computing Engineer • AI/ML Systems Builder
Expert in cluster architecture, Dockerized microservices, large-scale GPU pipelines, and end-to-end computational biology engines.